List of companies in Lundbeckfonden Ventures's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
SNIPR Biome is a developer of microbial CRISPR-medicine founded in 2011 by Christian Groendahl, Morten O. A. Sommer and Jasper Clube. | ||||||
Developer of OncoMimics™ immunotherapy to treat follicular lymphoma. | ||||||
VarmX is a Netherlands-based biotechnology company manufacturing therapeutic proteins to restore blood clotting in bleeding patients. | ||||||
IO Biotech is a cancer Vaccines founded in 2014 by Mai-Britt Zocca, PhD, Professor Mads Hald Andersen, Anders Ljungqvist, Professor MD PhD Inge Marie Svane and Professor Per Thor Straten. | ||||||
Aura Biosciences is a Boston, Massachusetts-based biotechnology company developing nanoparticle therapies to treat cancer. | ||||||
Imara is a Cambridge, Massachusetts-based biotechnology company. | ||||||
A company developing drugs for orphan and rare diseases | ||||||
Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs. | ||||||
Trevi Therapeutics is a small Molecules founded in 2011 by Jennifer L. Good. | ||||||
Lexeo Therapeutics is a gene Therapy founded in 2018 by Ronald Crystal. | ||||||
Reneo Pharmaceuticals is a Genetically-Defined Orphan Therapies. | ||||||
NMD Pharma is a small Molecule Drug Discovery founded in 2015. | ||||||
Falck is a Copenhagen-based healthcare company founded in 1906 by Sophus Falck. | ||||||
AFYX Therapeutics is a topical Drug Delivery for Mucosal Diseases founded in 2013. | ||||||
Treatments for rare neuroendocrine tumors and rare endocrine diseases | ||||||
Reneo Pharma Ltd is a Sandwich, Kent-based company founded in 2018. | ||||||
Kvantify is a quantum computing powered drug discovery platform founded in 2022. | ||||||
Small Molecules |
